Walter Sisulo University, Mthata, South Africa.
PLoS Negl Trop Dis. 2009 Dec 8;3(12):e562. doi: 10.1371/journal.pntd.0000562.
Few studies have estimated prevalence of neurocysticercosis (NCC) among persons with epilepsy in sub-Saharan Africa. While the limitations of serological testing in identification of NCC are well known, the characteristics of persons who are misdiagnosed based on serology have not been explored. The first objective of this pilot study was to estimate the prevalence of NCC in epilepsy outpatients from an area of South Africa endemic for cysticercosis. The second objective was to estimate the accuracy of serological testing in detecting NCC in these outpatients and characterize sources of disagreement between serology and neuroimaging.
METHODOLOGY/PRINCIPAL FINDINGS: All out-patients aged 5 or older attending the epilepsy clinic of St. Elizabeth's Hospital in Lusikisiki, Eastern Cape Province, between July 2004 and April 2005 were invited to participate. Epidemiological data were collected by local study staff using a standardized questionnaire. Blood samples were tested by ELISA for antibody and antigen for Taenia solium. Four randomly chosen, consenting participants were transported each week to Mthatha for brain CT scan. The proportion of persons with epilepsy attending St. Elizabeth clinic with CT-confirmed NCC was 37% (95% CI: 27%-48%). Using CT as the gold standard, the sensitivity and specificity of antibody testing for identifying NCC were 54.5% (36.4%-71.9%) and 69.2% (52.4%-83.0%), respectively. Sensitivity improved to 78.6% (49.2%-95.3%) for those with active lesions. Sensitivity and specificity of antigen testing were considerably poorer. Compared to false negatives, true positives more often had active lesions. False positives were more likely to keep pigs and to have seizure onset within the past year than were true negatives.
CONCLUSIONS/SIGNIFICANCE: The prevalence of NCC in South African outpatients with epilepsy is similar to that observed in other countries where cysticercosis is prevalent. Errors in classification of NCC using serology alone may reflect the natural history of NCC.
在撒哈拉以南非洲,很少有研究估计过神经囊虫病(NCC)在癫痫患者中的流行率。虽然血清学检测在识别 NCC 方面存在局限性已得到充分证实,但基于血清学检测误诊的患者特征尚未得到探讨。这项初步研究的第一个目标是估计南非一个囊虫病流行地区的癫痫门诊患者中 NCC 的流行率。第二个目标是估计血清学检测在这些门诊患者中检测 NCC 的准确性,并描述血清学与神经影像学之间的不一致来源。
方法/主要发现:2004 年 7 月至 2005 年 4 月期间,邀请所有年龄在 5 岁及以上的在东开普省卢西基西基圣伊丽莎白医院癫痫科就诊的门诊患者参加本研究。当地研究人员使用标准化问卷收集流行病学数据。采用酶联免疫吸附试验(ELISA)检测血清中的抗绦虫抗体和抗原。每周随机选择 4 名同意的参与者送往姆塔塔进行脑 CT 扫描。在接受 CT 扫描的患者中,患有经 CT 证实的 NCC 的癫痫患者比例为 37%(95%置信区间:27%-48%)。以 CT 扫描为金标准,抗体检测识别 NCC 的敏感性和特异性分别为 54.5%(36.4%-71.9%)和 69.2%(52.4%-83.0%)。对于有活动病灶的患者,敏感性提高至 78.6%(49.2%-95.3%)。抗原检测的敏感性和特异性则较差。与假阴性相比,真阳性更常出现活动病灶。假阳性患者更有可能养猪且发病时间在过去一年以内,而真阴性患者则相反。
结论/意义:南非癫痫门诊患者中 NCC 的流行率与其他囊虫病流行地区相似。单独使用血清学进行 NCC 分类的错误可能反映了 NCC 的自然史。